Urovant Sciences Announces Submission of New Drug Application for Vibegron for the Treatment of Overactive Bladder
IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Dec 30, 2019--
IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Dec 30, 2019--